The members of the staff are committed to ensuring high
quality patient services.
Supervisory talent capable of mentoring clerical and junior staff members toward heightened professionalism and
quality patient service.
Engaging EKG Technician able to provide
quality patient service through efficient electrocardiogram delivery and performance of stress tests.
Certified and highly trained CT and Radiology with 3 years clinical developed skills and experience in all facets of Radiology and CT support with extensive
quality patient service.
Certified and highly trained CT and Radiology with 3 years educational and clinical developed skills with experience in all facets of Radiology and CT support providing
quality patient service.
Current Radiology student boasting current GPA of 3.75 seeking a role in MRI as an assistant providing
quality patient service and imaging support.
Meets all professional nursing standards and pertinent local, state and federal requirements to perform superior nursing care, and to maintain and deliver
quality patient service and support.
Certified and highly trained Radiography Professional with U.S. Military training and 3 years experience in Radiography — providing extensive
quality patient service.
Not exact matches
Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward - looking statements include, among others, the following: our ability to successfully and profitably market our products and
services; the acceptance of our products and services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form
services; the acceptance of our products and
services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form
services by
patients and healthcare providers; our ability to meet demand for our products and
services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form
services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and diagnostic products and
services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form
services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and
services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form
services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and
quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form
quality metrics issued by various organizations such as the U.S. Preventive
Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form
Services Task Force, the American Cancer Society, and the National Committee for
Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form
Quality Assurance regarding cancer screening or our products and
services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form
services; our ability to successfully develop new products and
services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form
services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 10 - Q.
PROMs are questionnaires that
patients complete that assess how health
services and interventions have, over time, affected their
quality of life, daily functioning, symptom severity, and other dimensions of health, which only
patients can know.
By retaining healthcare professionals, healthcare organizations avoid frequent hiring costs and develop a more experienced workforce, which delivers higher
quality service and facilitate higher levels of
patient care with greater efficiency.
RxAdvance is a national full -
service pharmacy benefit manager that leverages Collaborative PBM Cloud ™ to deliver integrated PBM
services that reduce overall pharmacy costs, optimize specialty spend by converting from «buy and bill» to «authorize and manage», and reduce avoidable drug - impacted medical costs while improving
patient's
quality of life with unmatched regulatory compliance and transparency.
Its tailored, world - class
services that reduce overall pharmacy costs, reduce avoidable drug impacted medical costs, and optimize specialty drug spend while improving
patient quality of life are for all plan sponsors — health plans, accountable care organizations (ACOs), exchanges, state Medicaid programs, and employer groups.
RxAdvance is a national full -
service pharmacy benefit manager that leverages Collaborative PBM Cloud ™ to deliver integrated PBM
services through three distinct
service offerings: nirvanaRxCloud ™, a cloud - based, full -
service PBM solution that reduces overall pharmacy costs; nirvanaAccountableCare ™, a risk - sharing solution to reduce avoidable drug - impacted medical costs; and nirvanaSpecialty ™, a solution to convert specialty drug treatment management from «Buy & Bill» to «Authorize & Manage», while improving
patient's
quality of life with unmatched regulatory compliance and transparency.
RxAdvance is a national full -
service pharmacy benefit manager that leverages Collaborative PBM Cloud ™ to deliver integrated PBM
services that reduce overall pharmacy costs, optimize specialty spend by converting from «buy and bill» to «manage and authorize», and reduce avoidable drug - impacted medical costs while improving
patient's
quality of life with unmatched regulatory compliance and transparency.
When healthcare providers are caught up with administering
quality services, medical eligibility verification tasks are left unattended and may give rise to problems like delayed or non-payment, errors, claim rejections, and dissatisfaction among
patients.
With the hectic schedule involved in providing
quality patient care while managing staff at the same time, partnering with Infinit Healthcare for outsourced medical billing can help you manage forthcoming alterations to the system and ensure a more accurate billing of
services.
«At a time when
patients are already waiting too long for
quality health care, it's unacceptable for Christy Clark and her government to further reduce
services.
Focusing on
quality and customer
service, 101 Mobility provides seniors and disabled individuals with professional, established mobility solutions that include stair lifts, auto lifts, ramps, vertical platform lifts, residential elevators,
patient lifts, medical alert
services, power chairs, pool lifts, power scooters and more.
The programme of work on
patient safety looks at both the translation of novel technologies into health care and innovative ways of organising
services differently to bridge «gaps» in care and improve
quality and safety for
patients.
Jane is programme director in the NIHR King's
Patient Safety and
Service Quality Research Centre leading a programme of work on innovations in service quality and health techno
Service Quality Research Centre leading a programme of work on innovations in service quality and health techno
Quality Research Centre leading a programme of work on innovations in
service quality and health techno
service quality and health techno
quality and health technologies.
Our Las Vegas fertility clinic is an international destination for high -
quality fertility care, thanks to our world - renowned research, extremely high success rates, decades of experience and commitment to
patient service.
ViaCord provides the highest
quality stem cell preservation
service and care to our
patients, families, and their physicians.
The Pacific Fertility Egg Bank is a full -
service program that eases
patients through the process while never compromising on
quality.
«Hospitals need to be fully prepared as early as possible to minimise disruption to
services and maintain high
quality patient care.
«Under the proposed changes it will be easier for an unskilled Australian bar worker to stay in the UK for two years than a skilled Sudanese Doctor who wants to come to Britain to receive medical training that saves lives, and make a contribution to providing high
quality services to
patients in the UK.»
These
services will help former
patients improve their
quality of life and greatly reduce the likelihood of relapse.
«However existing
patient services have been given a clean bill of health by the Care
Quality Commission.»
«The joint guidelines give recommendations for improved provision of fertility preservation treatments for both men and women and should be heeded by healthcare professionals,
service providers and policy makers responsible for providing good
quality care to these
patients.»
In addition, «clinical
quality indicators» were introduced in April 2011 to allow
patients and the public to see the
quality of care provided by ambulance
services.
The Mall will utilize an «Inter-Professional» health model, which offers comprehensive health
services to
patients by multiple health providers working collaboratively to deliver
quality care within and across settings.
Eighty - nine per cent agreed that the measures would lead to a fragmentation of
services, while 65 % of respondents agreed that the
quality of
patient care would be reduced as a result.
Patients attending a clinic run by the King's College London Dental Institute Health Psychology
Service at Guy's and St Thomas» NHS Foundation Trust were surveyed for their levels of dental anxiety, general anxiety, depression, suicidal thoughts, alcohol use and oral health - related
quality of life.
This is important, because when rating
quality measures for nursing homes,
patients and experts at the Centers for Medicare and Medicaid
Services (CMS) usually don't agree on what is best, leading UCI researchers to conclude that
patients may benefit from a more personalized approach to choosing a nursing home.
The previous research examined how team training impacted
quality of care, customer
service,
patient satisfaction and other variables.
Jason Acker of the Canadian Blood
Services is interested in seeing if this technology can be used to test the blood the
service stores, which he says could enhance the
quality of
patient transfusions.
Equipped with some of the best technologies for neuroimaging and intervention, it provides
quality clinical
services for
patients and certified advanced training for the region?s newly qualified neurosurgeons.
Its mission is to increase access to and improve the
quality of addiction treatment, to educate physicians, and other health care providers and the public, to support research and prevention, to promote the appropriate role of the physician in the care of
patients with addictive disorders, and to establish addiction medicine as a specialty recognized by professional organizations, governments, physicians, purchasers and consumers of health care
services and the general public.
The pediatric hematology oncology program at Hasbro Children's Hospital offers the highest
quality, state - of - the - art treatments for
patients with a variety of blood diseases and cancers, as well as infusion
services.
The ACO will map
services to Medicaid
patients» physical location and medical needs, while addressing psychosocial barriers that often limit access to high -
quality care.
Offering a safe, comprehensive approach to treating adult and teen obesity, the award - winning Center for Bariatric Surgery provides personalized,
quality care and multidisciplinary
services ranging from long - term nutritional and behavior modification and
patient support groups to a full complement of bariatric surgeries and state - of - the - art laparoscopic and minimally invasive technologies.
All of the entities within the health system possess their own distinct environment, but all share the same philosophy: a dedication to high -
quality patient care and
service, and advancing medicine through research and education.
TNGB provides the scientific community and
patient organisations with an efficient
service of the highest
quality standards, according to rigorous ethical principles in compliance with Italian laws and international recommendations.
Colleen Snydeman, director of
quality and safety for
Patient Care
Services at Massachusetts General Hospital, felt the full force of Hurricane Maria three weeks after September 20, 2017, the day the storm devastated Puerto Rico.
Since its beginning in 1902, Cedars - Sinai has evolved to meet the healthcare needs of one of the most diverse regions in the nation, continually setting new standards in
quality and innovation in
patient care, research, teaching and community
service.
We are examining ways to improve and support the responsible sharing of data by NHS clinical genetics / genomics
services for
patient benefit,
patient safety and
service quality
Senior author Dr Paul Chapman, from the Melanoma and Sarcoma
Service at Memorial Sloan - Kettering Cancer Centre, said, «We have seen many tumours shrink rapidly and, in some
patients,
quality of life improved dramatically.
This affiliation agreement with Huntsman Cancer Institute supports that effort by streamlining coordination of care and
services with a nationally ranked and regionally respected healthcare organization focused on providing the highest
quality of care for cancer
patients.
Rich, interoperable datasets are essential both for high -
quality research and for translating this research into better clinical
services and outcomes for
patients.
In a substudy, review outcomes were also compared across different types of clinical research, based in large part on the designations and definitions derived from a number of sources, including a report by Nathan, 14 the Institute of Medicine, 20 the NIH Director's Panel on Clinical Research, 9 the Association of American Medical Colleges and American Medical Association, 21 and the Agency for Healthcare Research and
Quality.22 All 3599 R01 applications involving human subjects that were submitted to NIH for the October 2002 council were categorized into 1 of the following: (1)
patient - oriented studies of mechanisms of human disease (bench to bedside); (2) clinical trials and other clinical interventions; (3)
patient - oriented research focusing on development of new technologies; (4) epidemiological studies; (5) behavioral studies (including studies of normal human behavior); (6) health
services research; and (7) use of deidentified human tissue.